Hepatomax forte capsules No. 30
Composition
| Active ingredients | Contents in 1 capsule |
| milk thistle seed extract (silymarin) | 140 mg |
| enriched phospholipids (lecithin) | 100 mg |
| alpha-lipoic acid | 50 mg |
| excipients (lactose, starch, calcium or magnesium stearate) | 110 mg |
Recommendations for use
Enriched phospholipids, silymarin and alpha-lipoic acid, which are part of HEPATOMAX® FORTE, are used:
- for the prevention of toxic effects on the liver associated with prolonged use of medications (antibiotic therapy, chemotherapy, etc.), alcohol consumption, smoking, and exposure to adverse environmental factors;
- as a concomitant agent for normalizing digestion, metabolism and the activity of the hepatobiliary zone in allergic and skin diseases;
- as an aid for normalizing digestion, metabolism, and the activity of the hepatobiliary zone when taking medications aimed at reducing excess body weight;
- in the complex therapy of chronic hepatitis of various etiologies, liver cirrhosis.
Method of administration and doses
Adults and children over 12 years old: 1-2 capsules three times a day during meals, washed down with water. The course of administration is 30-40 days. A break of 2 weeks. If necessary, the course can be repeated.
Children from 8 to 12 years old: 1 capsule three times a day during meals, washed down with water. The course of administration is 30-40 days. A break of 2 weeks. If necessary, the course can be repeated.
If prescribed by a doctor, long-term use for 4-6 months is possible.
As a preventive measure: 1 capsule 2 times a day with meals for 30-40 days. Break 2 weeks. If necessary, the course can be repeated.
A doctor's consultation is required before use.
Reservation
Individual sensitivity to components, children under 8 years of age.
Application features
The use of HEPATOMAX® FORTE by women during pregnancy and lactation is possible only as prescribed by a doctor.
HEPATOMAX® FORTE does not affect the ability to drive or use machines.
Alpha-lipoic acid, which is part of HEPATOMAXA® FORTE, may enhance the hypoglycemic (sugar-lowering) effect of insulin or oral antidiabetic agents, therefore, in the first days of taking HEPATOMAXA® FORTE, more frequent monitoring of blood sugar levels should be performed.
Alpha-lipoic acid forms complex compounds with metal ion complexes, therefore it is not recommended to use HEPATOMAX® FORTE with iron, magnesium, platinum, etc. preparations - due to a possible decrease in their effectiveness.
Overdose
When using HEPATOMAX® FORTE in unreasonably high doses, dyspeptic phenomena (nausea, vomiting, diarrhea) are possible. Symptomatic treatment, gastric lavage, and administration of enterosorbents are indicated.
Release form
Capsules 400 mg, blister, No. 30.
Storage conditions
Store in the manufacturer's packaging, in a dry place, protected from light, at a temperature of 18°C to 25°C and a relative humidity of no more than 75%, 24 months from the date of manufacture.
Keep out of reach of children.
Dietary supplement from plant raw materials for the diet. Not a medicinal product. Dietary supplements should not be used as a substitute for a balanced diet. Do not exceed the recommended daily intake.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.